C&O Pharmaceutical Technology Holdings Ltd

911-12 Silvercord Tower 2 30 Canton Road,
Tsim Sha Tsui,
Hong Kong,
(852)2806-0109
www.changao.com

C&O is an integrated pharmaceutical group in China. Its activities span research & development, manufacturing, and marketing and distribution of C&O and third party brand products.

C&O Pharmaceutical Technology Holdings was acquired by Shionogi & Co on August 01, 2011.

Join Mergr to view all 306 acquisitions of healthcare services companies in 2011, including 74 acquisitions by private equity firms, and 232 by strategics.

Out of 60 sectors in the Mergr database, healthcare services ranked 4 in number of deals in 2011. The largest healthcare services acquisition in 2011 was Pharmaceutical Product Development - which was acquired by Hellman & Friedman for $3.9B.

Join Mergr to view this profile - and discover more healthcare services acquisitions of companies like C&O Pharmaceutical Technology Holdings.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.